THE ECONOMIC IMPACT OF REDUCING BLEEDING WITH EMICIZUMAB IN PATIENTS WITH HEMOPHILIA A AND FACTOR VIII INHIBITORS - BRAZILIAN CASE

被引：0
|
作者：
Segre, N. [1 ]
Mata, V [1 ]
Martins, T. D. C. [1 ]
机构：
[1] F Hoffmann La Roche, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE559
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [41] Eradication of factor viii inhibitors in patients with mild and moderate hemophilia A
    Kempton, Christine L.
    Allen, Geoff
    Hord, Jeffrey
    Kruse-Jarres, Rebecca
    Pruthi, Rajiv K.
    Walsh, Christopher
    Young, Guy
    Soucie, J. Michael
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 933 - 936
  • [42] Factor VIII inhibitors in patients with non-severe hemophilia
    Kempton, C. L.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 78 - 79
  • [43] THE INCIDENCE OF FACTOR-VIII INHIBITORS IN PATIENTS WITH HEMOPHILIA-A
    SCHWARZINGER, I
    LECHNER, K
    NIESSNER, H
    PABINGER, I
    [J]. HAEMOSTASIS, 1985, 15 (01) : 17 - 17
  • [44] Factor VIII inhibitors in hemophilia a patients with different treatment modalities
    Abdel-Halim, Afifi O.
    Abdul-Azeem, Argoon S.
    Abdel-Rahman, Ahmad Y.
    Thabet, N. M.
    Abdul-All, R. F.
    Mohamed, G. G.
    Thabet, A. F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 100 - 100
  • [45] Acquired hemophilia due to factor VIII inhibitors in 34 patients
    Bossi, P
    Cabane, J
    Ninet, J
    Dhote, R
    Hanslik, T
    Chosidow, O
    Jouan-Flahault, C
    Horellou, MH
    Leynadier, F
    Liozon, E
    Pouchot, J
    Robin, JP
    Sanderson, F
    Schaeffer, A
    Sicard, D
    Staikowsky, F
    Wechsler, B
    Zittoun, R
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 105 (05): : 400 - 408
  • [46] Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
    Lee, Min Young
    Lee, Woo In
    Kang, So Young
    Kim, Myeong Hee
    Park, Young Shil
    [J]. ANNALS OF LABORATORY MEDICINE, 2023, 43 (01) : 96 - 99
  • [47] USE OF CHROMOGENIC FACTOR VIII ACTIVITY DETERMINATION IN HEMOPHILIA A PLASMA OF PATIENTS UNDER EMICIZUMAB TREATMENT
    Unterberger, M.
    Wagner, L.
    Binder, N. B.
    [J]. HAEMATOLOGICA, 2019, 104 : 17 - 17
  • [48] Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: A case report
    Heiland, M
    Weber, M
    Schmelzle, R
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 61 (11) : 1350 - 1353
  • [49] Laboratory and Bleeding Frequency Changes in Pediatric Patients after Transitioning from Factor VIII to Emicizumab Prophylaxis -Real World Evidence in Patients with Severe Hemophilia a
    Jain, Akshat
    Sheth, Parthiv V.
    [J]. BLOOD, 2023, 142
  • [50] Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement
    Santagostino, Elena
    Elisa Mancuso, Maria
    Novembrino, Cristina
    Solimeno, Luigi Piero
    Tripodi, Armando
    Peyvandi, Flora
    [J]. HAEMATOLOGICA, 2019, 104 (08) : E380 - E382
12345